Capsule Filler Resources

31. Strategies For De-Risking Early-Phase Oral Small Molecule Drug Development 3/7/2022

    A team of experts discuss risk-reduction strategies, critical formulation considerations, and careful technology selection to stretch the often limited quantities of API available for early studies.

32. Examining The Emergence Of Unit- And Bi-Dose Nasal Sprays 2/8/2022

    Nasal spray administration of medicine offers advantages over oral and IV delivery. Experts discuss the advantages and opportunities of adopting unit- and bi-dose nasal delivery technology.

33. Aligning Pediatric Patient Needs With Drug Development Success 8/15/2024

    Executive Director of Pharmaceutical Sciences Srinivasan Shanmugam, Ph.D., discusses pediatric patient compliance, regulations impacting trial access, excipients within formulations, and more.

34. How To Support At Every Stage Of The Clinical Cycle 9/28/2022

    Alan Lahaise, VP, Business Development, Manufacturing and EMEA Clinical Services, discusses core clinical trials services, how to tackle the structural complexity of modern biologics, and regulatory considerations.

35. Measuring Aspects Of Health In Heart Failure Research 4/17/2024

    Dr. Bill Byrom sat with Cardiology Professor Marianna Fontana to discuss opportunities for measuring aspects of health meaningful for increasing the usefulness of COA measures in heart failure trials.

36. Reduce The Environmental Footprint Of Oligonucleotides 3/7/2023

    Industry experts answer attendees' questions from a recent webinar about sustainability concerns surrounding oligonucleotide manufacturing.

37. Downstream Process Development Customer Service 5/28/2024

    This question-and-answer session explores a variety of technical support services available to help in the implementation of Praesto™ chromatography resins.

38. Sustainability Goals Impacting Biopharma 6/17/2024

    What are some of the new trends in the pharmaceutical industry spurred on by mAbs and other advanced therapies, and how is sustainability influencing business practices?

39. Optimizing Oncology And Rare Disease Clinical Trials By Focusing On Science And Aligning With Both Patients And Investigators 5/6/2025

    Dive into the history and accomplishments of Ergomed, a mid-sized, full-service contract research organization (CRO), with a specialized focus on oncology and rare disease clinical research.

40. A Guide To Protein Engineering 10/25/2024

    Almost every facet of an antibody can be modified. Explore antibody humanization, the importance of affinity and function, isotype selection, and the development of bispecific and antibody-drug conjugates (ADCs).